Bjartmar Carl
Chief Medical Officer
Business development
Wilson Therapeutics
Sweden
Biography
Education: MD and Ph.D. in neuroscience, University of Linköping. Other current assignments: – Previous assignments (last five years): Senior medical director of Sanofi-Aventis AB and Genzyme AB. Holdings in the Company: 3,500 ordinary shares, 150,500 stock options and 20,000 performance shares LTIP 2017.
Research Interest
